scholarly journals A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

2017 ◽  
Vol 182 (3) ◽  
pp. 429-433 ◽  
Author(s):  
Guy Pratt ◽  
Christina Yap ◽  
Ceri Oldreive ◽  
Daniel Slade ◽  
Rebecca Bishop ◽  
...  
Keyword(s):  
Phase I ◽  
Chronic Lymphocytic Leukaemia ◽  
Mantle Cell Lymphoma ◽  
Phase I Trial ◽  
Lymphocytic Leukaemia ◽  
Cell Lymphoma ◽  
Parp Inhibitor ◽  
Prolymphocytic Leukaemia ◽  
Mantle Cell

Synchronous Mantle Cell Lymphoma, Chronic Lymphocytic Leukaemia and Melanoma in a Single Lymph Node

2010 ◽  
Vol 123 (3) ◽  
pp. 194-196 ◽  
Author(s):  
Juanah Addada ◽  
Parameswaran Anoop ◽  
John G. Swansbury ◽  
Andy Wotherspoon ◽  
J. Meirion Thomas ◽  
...  
Keyword(s):  
Lymph Node ◽  
Chronic Lymphocytic Leukaemia ◽  
Mantle Cell Lymphoma ◽  
Lymphocytic Leukaemia ◽  
Cell Lymphoma ◽  
Mantle Cell

OAsis: An international phase I trial of obinutuzumab, venetoclax plus ibrutinib in relapsed/refractory mantle cell lymphoma.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. TPS7583-TPS7583 ◽  
Author(s):  
Steven Le Gouill ◽  
Andrew Davies ◽  
Kamal Bouabdallah ◽  
David Chiron ◽  
Simon Rule
Keyword(s):  
Phase I ◽  
Mantle Cell Lymphoma ◽  
Phase I Trial ◽  
Cell Lymphoma ◽  
Mantle Cell

scholarly journals Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma

2010 ◽  
Vol 101 (1) ◽  
pp. 196-200 ◽  
Author(s):  
Takashi Watanabe ◽  
Harumi Kato ◽  
Yukio Kobayashi ◽  
Satoshi Yamasaki ◽  
Yuriko Morita-Hoshi ◽  
...  
Keyword(s):  
Phase I ◽  
Mantle Cell Lymphoma ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Phase I Trial ◽  
Cell Lymphoma ◽  
Potential Efficacy ◽  
Deacetylase Inhibitor ◽  
Mantle Cell

scholarly journals Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

2014 ◽  
Vol 25 (10) ◽  
pp. 2020-2024 ◽  
Author(s):  
D.J. Inwards ◽  
P.A. Fishkin ◽  
B.R. LaPlant ◽  
M.T. Drake ◽  
P.J. Kurtin ◽  
...  
Keyword(s):  
Phase I ◽  
Mantle Cell Lymphoma ◽  
Phase I Trial ◽  
Cell Lymphoma ◽  
Initial Therapy ◽  
Mantle Cell

scholarly journals Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma

2010 ◽  
Vol 151 (1) ◽  
pp. 47-53 ◽  
Author(s):  
Jorge E. Romaguera ◽  
Luis E. Fayad ◽  
Peter McLaughlin ◽  
Barbara Pro ◽  
Alma Rodriguez ◽  
...  
Keyword(s):  
Phase I ◽  
Mantle Cell Lymphoma ◽  
Phase I Trial ◽  
Cell Lymphoma ◽  
Mantle Cell
Sign in / Sign up

Export Citation Format

Share Document